activins has been researched along with zoledronic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anastasilakis, AD; Gkiomisi, A; Makras, P; Papatheodorou, A; Polyzos, SA; Savvides, M; Terpos, E | 1 |
Coleman, RE; Holen, I; Ottewell, P; Wilson, C | 1 |
2 other study(ies) available for activins and zoledronic acid
Article | Year |
---|---|
Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment.
Topics: Activins; Age Factors; Aged; Aging; Biomarkers; Bone Density; Bone Density Conservation Agents; Case-Control Studies; Diphosphonates; Female; Femur Neck; Humans; Imidazoles; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Zoledronic Acid | 2013 |
The differential anti-tumour effects of zoledronic acid in breast cancer - evidence for a role of the activin signaling pathway.
Topics: Activins; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Female; Follistatin; Humans; Imidazoles; MCF-7 Cells; Mice; Phosphorylation; Receptors, Estrogen; Signal Transduction; Smad2 Protein; Xenograft Model Antitumor Assays; Zoledronic Acid | 2015 |